An observational study in Hepatocellular Carcinoma, sponsored by University of Texas Southwestern Medical Center. Withdrawn. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2014-05-19.
Sponsored by University of Texas Southwestern Medical Center · Observational
To collect tumor tissue from patients with liver masses suspicious for primary liver cancer. The research biopsy will be used to identify biomarkers in future studies.
In this study patients are referred to the Department of Radiology for an image-guided (either CT or ultrasound) core needle biopsy of a liver mass suspicious for primary liver cancer as a part their clinical care. A written informed consent will be obtained for the clinical biopsy per standard protocol. Additional core biopsy of the liver mass will be performed for research purposes at the time of the clinical care biopsy. The additional research biopsy is not mandatory and is subject to a separate written informed consent, which will be obtained prior to the clinical biopsy.
3,182 studies on the registry are indexed under Carcinoma, Hepatocellular; 954 are open to participants now.
Browse Carcinoma, Hepatocellular studies →University of Texas Southwestern Medical Center is the lead sponsor of 990 studies on the registry; 201 are open to participants now.
Of its 135 completed or terminated interventional studies of FDA-regulated products, 100 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
500 patients with a liver mass suspicious for HCC
Adequate organ and marrow function as defined below:
INR ≤ 1.5 platelets ≥ 70,000/mcl
Exclusion Criteria:
Patients that have liver masses suspicious for primary liver cancer.
Biopsy of Liver Masses
To obtain tissue from biopsy of liver masses suspicious for primary liver cancer for use in future biomarker studies.
Time frame: 5 years
No study locations are listed for this record.
This study is withdrawn, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas Southwestern Medical Center